Coeliac disease--a diagnostic and therapeutic challenge.
During the past 20 years the diagnosis of coeliac disease has improved significantly. However, at the same time the true prevalence of the condition has doubled, involving more than 2% of the population in some countries. Due to mild or atypical symptoms, the diagnosis remains a challenge for the health care system. Highly sensitive and specific serum endomysial and transglutaminase-2 antibody tests are helpful in identifying patients for diagnostic endoscopy and small-bowel biopsy. The diagnosis of the disease is still based on the demonstration of gluten-induced small-bowel mucosal villous atrophy with crypt hyperplasia. However, coeliac disease may manifest itself before the development of the overt small-intestinal lesion. Positive endomysial and transglutaminase antibodies in patients with normal small-bowel mucosal villous architecture may indicate early stage coeliac disease. Currently, the only effective treatment for the condition is a life-long strict gluten-free diet. Long-term regular follow-up of patients is recommended in order to maintain good adherence to the diet.
Kaukinen
Katri
K
Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland. katri.kaukinen@uta.fi
Lindfors
Katri
K
Collin
Pekka
P
Koskinen
Outi
O
Mäki
Markku
M
D000818:Animals; D002446:Celiac Disease / Q000175:diagnosis* / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D006801:Humans; D015995:Prevalence